Fri, 03 Mar 2023 11:45:02 +0100

Use of Warrants of Series TO1 in Scandinavian Real Heart AB

Press Release 3 March, 2023

Scandinavian Real Heart AB ("Realheart" or ''the Company'') today announces the outcome of the exercise of warrants of series TO1. A total of 7 183 148 warrants of series TO1 were exercised, corresponding to approximately 70 percent of the total number of warrants, which brings the Company approximately SEK 4.2 million before issuing related costs.

The subscription period ran from 1 - 28 February 2023 and the warrants were issued in connection with the Company's issuance of units in the third quarter of 2021. Four (4) warrants entitled the holder to subscribe for one (1) new share.

A total of 1,795,787 shares were subscribed for at the fixed subscription price of SEK 2.36. The exercise of the warrants increases the number of shares from 33 183 461 to 34 979 248. For existing shareholders, the dilution from the exercise of the warrants amounts to approximately 5.1 percent.

As soon as the issue has been registered with the Swedish Companies Registration Office and Euroclear, which is expected to take place in mid-March 2023, interim shares (IS) will be converted into ordinary shares and admitted to trading on the Nasdaq First North Growth Market.

Financial Advisor and Issuing Agent

Skills Corporate Finance Nordic AB is the financial advisor and Nordic Issuing AB is the issuing agent to Realheart in connection with the exercise of warrants of series TO1.

For more information please contact:

Ina Laura Perkins, CEO

Phone: +46(0)70 406 49 21 


Certified Adviser: Svensk Kapitalmarknadsgranskning AB,

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.

Use of Warrants of Series TO1 in Scandinavian Real Heart AB (PDF)